Published on in Vol 12 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/43091, first published
.
![Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model](https://asset.jmir.pub/assets/2a16584a24cb0d7b5cd94147728f098e.png 480w,https://asset.jmir.pub/assets/2a16584a24cb0d7b5cd94147728f098e.png 960w,https://asset.jmir.pub/assets/2a16584a24cb0d7b5cd94147728f098e.png 1920w,https://asset.jmir.pub/assets/2a16584a24cb0d7b5cd94147728f098e.png 2500w)
There are currently no tweets available for this article within the specified range.